These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12408677)

  • 1. Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides.
    Kirsch C; Eckert GP; Mueller WE
    Amyloid; 2002 Sep; 9(3):149-59. PubMed ID: 12408677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol modulates amyloid beta-peptide's membrane interactions.
    Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.
    Eckert GP; Cairns NJ; Maras A; Gattaz WF; Müller WE
    Dement Geriatr Cogn Disord; 2000; 11(4):181-6. PubMed ID: 10867442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin effects on cholesterol micro-domains in brain plasma membranes.
    Kirsch C; Eckert GP; Mueller WE
    Biochem Pharmacol; 2003 Mar; 65(5):843-56. PubMed ID: 12628479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain membrane cholesterol domains, aging and amyloid beta-peptides.
    Wood WG; Schroeder F; Igbavboa U; Avdulov NA; Chochina SV
    Neurobiol Aging; 2002; 23(5):685-94. PubMed ID: 12392774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane disordering effects of beta-amyloid peptides.
    Eckert GP; Wood WG; Müller WE
    Subcell Biochem; 2005; 38():319-37. PubMed ID: 15709486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes.
    Subasinghe S; Unabia S; Barrow CJ; Mok SS; Aguilar MI; Small DH
    J Neurochem; 2003 Feb; 84(3):471-9. PubMed ID: 12558967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.
    Gibson Wood W; Eckert GP; Igbavboa U; Müller WE
    Biochim Biophys Acta; 2003 Mar; 1610(2):281-90. PubMed ID: 12648781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
    Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2070-5. PubMed ID: 14970312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
    Vestergaard M; Hamada T; Morita M; Takagi M
    Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-disordering effects of beta-amyloid peptides.
    Müller WE; Kirsch C; Eckert GP
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):617-23. PubMed ID: 11498039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity.
    Hartmann H; Eckert A; Müller WE
    Biochem Biophys Res Commun; 1994 May; 200(3):1185-92. PubMed ID: 8185566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-dependent aggregation of amyloid beta-protein.
    Yanagisawa K; Matsuzaki K
    Ann N Y Acad Sci; 2002 Nov; 977():384-6. PubMed ID: 12480776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells.
    Ng J; Kamm RD; Wohland T; Kraut RS
    J Mol Biol; 2018 Sep; 430(18 Pt B):3439-3453. PubMed ID: 29746852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid membranes and beta-amyloid: a harmful connection.
    Eckert GP; Wood WG; Müller WE
    Curr Protein Pept Sci; 2010 Aug; 11(5):319-25. PubMed ID: 20423299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes.
    Eckert GP; Wood WG; Müller WE
    J Neural Transm (Vienna); 2001; 108(8-9):1051-64. PubMed ID: 11716141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin Differentially Affects Neuronal Cholesterol and Amyloid-β Production in vivo and in vitro.
    Mendoza-Oliva A; Ferrera P; Fragoso-Medina J; Arias C
    CNS Neurosci Ther; 2015 Aug; 21(8):631-41. PubMed ID: 26096465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amyloid β-peptide on the fluidity of phosphatidylcholine membranes: Uses and limitations of diphenylhexatriene fluorescence anisotropy.
    Suzuki M; Miura T
    Biochim Biophys Acta; 2015 Mar; 1848(3):753-9. PubMed ID: 25497764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the interactions between β-amyloid peptide and the membranes of human SK-N-SH cells.
    Liu R; Tian T; Jia J
    FEBS Lett; 2015 Jul; 589(15):1929-34. PubMed ID: 26028312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.